|
Apr 2
|
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 14
|
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag
|
|
Mar 13
|
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
|
|
Mar 9
|
Director Gary Pace Sells 119,323 Shares of Pacira BioSciences Inc (PCRX)
|
|
Mar 6
|
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
|
|
Mar 5
|
11 Best Small Cap Pharma Stocks to Invest In
|
|
Feb 1
|
G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams
|
|
Jan 5
|
Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong
|
|
Jan 4
|
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
|
|
Jan 3
|
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 6
|
Hedge Funds are Betting on These 14 Sliding Stocks
|
|
Nov 13
|
Pacira (PCRX) Gets FDA Nod for Exparel's Label Expansion
|
|
Nov 10
|
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
|
|
Nov 7
|
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
|
|
Nov 4
|
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Are Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
|
|
Nov 2
|
Pacira (PCRX) Q3 Earnings and Revenues Miss, '23 View Updated
|
|
Nov 2
|
Pacira BioSciences Inc (PCRX) Reports Q3 2023 Financial Results
|
|
Nov 2
|
Pacira BioSciences Reports Third Quarter 2023 Financial Results
|
|
Sep 27
|
Unraveling the Future of Pacira BioSciences Inc (PCRX): A Deep Dive into Key Metrics
|